Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
TRICYCLIC COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/041634
Kind Code:
A1
Abstract:
The present disclosure provides a compound having USP1 inhibitory activity or functionality and a pharmaceutically acceptable salt thereof. The present disclosure further provides a pharmaceutical composition comprising the compound represented by formula (I) or a pharmaceutically acceptable salt thereof, and use thereof as a USP1 inhibitor in preventing or treating a related disease.

More Like This:
WO/1995/025104NOVEL HETEROCYCLIC ETHANOLAMINE DERIVATIVES WITH BETA-ADRENORECEPTOR AGONISTIC ACTIVITY
WO/2006/074940MACROCYCLIC COMPOUNDS AND COMPOSITIONS USEFUL AS BACE INHIBITORS
JP6281952HIV replication inhibitor
Inventors:
ZHU WEI (CN)
CHEN XIANG (CN)
WANG TAO (CN)
SUN TIANWEN (CN)
LI ZHENGTAO (CN)
Application Number:
PCT/CN2023/114915
Publication Date:
February 29, 2024
Filing Date:
August 25, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SIMCERE ZAIMING PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D291/08; A61K31/519; A61P35/00; C07D273/00; C07D417/14
Domestic Patent References:
WO2022214053A12022-10-13
WO2023083297A12023-05-19
WO2023148643A12023-08-10
Foreign References:
CN108473495A2018-08-31
CN113164485A2021-07-23
CN113474346A2021-10-01
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: USE OF FUSED RING PYRIMIDINE COMPOUND

Next Patent: VEHICLE SECURITY AUTHENTICATION METHOD